| Financial Year |
March 31 2023 |
| Monetary Funds |
318,573,629.24 |
| Held-for-trading Financial Assets |
432,210,698.14 |
| Notes Receivable |
-- |
| Accounts Receivable |
129,456,464.71 |
| Advances to Suppliers |
6,274,799.52 |
| Other Receivables |
8,277,290.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,109,408.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,477,718.46 |
| Total Current Assets |
1,039,380,009.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
111,519,705.02 |
| Investment Properties |
158,236,366.44 |
| Fixed Assetes |
436,857,538.83 |
| Under-construction Projects |
121,851,443.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,064,965.25 |
| R&D expenses |
-- |
| Goodwill |
292,533,842.30 |
| Long-Term Deferred and Prepaid Expenses |
20,501,107.06 |
| Deferred Income Tax Assets |
12,080,761.25 |
| Other Non-Current Assets |
8,530,827.93 |
| Sub-Total of Non-Current Assets |
1,398,742,653.39 |
| Total Assets |
2,438,122,662.94 |
| Short-Term Loans |
162,765,266.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,613,917.78 |
| Accounts Payable |
111,319,011.80 |
| Accounts Received In Advance |
1,788,090.02 |
| Employee Compensation Payable |
54,260,770.76 |
| Taxes Payable |
32,245,364.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,529,925.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,365,105.58 |
| Other Current Liabilities |
3,522,700.79 |
| Sub-Total of Current Liabilities |
475,914,158.32 |
| Long-term Loans |
104,422,034.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,852,716.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
164,680,693.57 |
| Total Liabilities |
640,594,851.89 |
| Paid-In Capital(Or Share Stock) |
293,322,218.00 |
| Capital Surplus |
651,728,507.95 |
| Surplus Reserve |
90,735,257.70 |
| LESS:Treasury Stock |
14,491,000.00 |
| Undistributed Profits |
773,404,353.97 |
| Minority Stockholder's Interest |
21,560,912.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,775,966,899.04 |
| Owner's Equity（Stockholder's Equity） |
1,797,527,811.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,438,122,662.94 |
